Announcements Trials
Browse Landscape

Phase

Phase 2 255Phase 3 132Phase 1 61Phase 1/2 57Phase 2/3 14Phase NA 8Phase 4 6Phase EARLY_PHASE1 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Genitourinary 1Breast 1

Conditions

EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 6pembrolizumab 5Oncolytic Virotherapy 4Magnetic Resonance Spectroscopy 4Fluorodeoxyglucose F18 4Carboplatin 4Paclitaxel 3Cyclophosphamide 3Cisplatin 3osimertinib 2atezolizumab 2aldesleukin 2Tobacco Use Cessation Devices 2Specimen Handling 2Radiotherapy 2Positron-Emission Tomography 2Pemetrexed 2Nivolumab 2Docetaxel 2toripalimab 1sugemalimab 1sodium thiosulfate 1perflutren 1palbociclib 1icotinib 1gallium 68 PSMA-11 1fludarabine 1durvalumab 1dapagliflozin 1dacomitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Docetaxel × Thoracic × Clear all
NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled
Thoracic

EGFR Positive Non-small Cell Lung Cancer

NCT02568033 2017-01-31

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

The Cooper Health System

Phase EARLY_PHASE1 Unknown
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡